1)sFlt-1可溶性血管内皮生长因子受体-1
1.The mRNA expression of sFlt-1 in placenta with hypertensive disorder comlicating pregnancy.;可溶性血管内皮生长因子受体-1的mRNA在妊娠高血压胎盘组织中的表达及意义
2.The Role of sFlt-1 in the Hypertension Disorder Compliction Pregnancy;可溶性血管内皮生长因子受体-1（sFlt-1）在妊娠期高血压疾病中的作用
英文短句/例句
1.The Study of the Relationship between the Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Preeclampsia;可溶性血管内皮生长因子受体-1与子痫前期发病关系的研究
2.Expression of Urinary Soluble Fms-like Tyrosine Kinase-1 with Preeclampsia尿可溶性血管内皮生长因子受体-1与子痫前期的关系及意义
3.The Role of sFlt-1 in the Hypertension Disorder Compliction Pregnancy;可溶性血管内皮生长因子受体-1（sFlt-1）在妊娠期高血压疾病中的作用
4.Effect of hypoxia on endothelial cells injury of human umbilical vein and expression of soluble vascular endothelial growth factor receptor-1 mRNA缺氧对脐静脉内皮细胞损伤及可溶性血管内皮生长因子受体-1 mRNA表达的影响
5.Cloning of Human Soluble Vascular Endothelial Growth Factor Receptor-1, 2 Gene and Research on Their Anti-tumor Effect on Experimental Lung Cancer;人可溶性血管内皮生长因子受体-1、2基因的克隆及其抗肺癌的实验研究
6.The Experimental Research about the Bone Marrow Stromal Cells Transfected by the Human Soluble VEGFR1;人可溶性血管内皮生长因子受体1转染骨髓基质细胞的实验研究
7.Vascular Endothelial Growth Factor and Its Soluble Receptor sFlt-1 in the Serum of Patients with Systemic Lupus Erythematosus;SLE患者中血管内皮生长因子及其可溶性受体1的表达及其意义
8.The Experimental Research on the Inhibition of Human Soluble Vascular Endothelial Growth Factor-1 on Leukemic Cell Proliferation;人可溶性血管内皮生长因子受体1对白血病细胞生长抑制作用的实验研究
9.Soluble Fms-Like Tyrosine Kinase-1 and Agonistic Autoantibody to the Angiotensin II Type 1 Receptor's Relationship with Preeclampsia可溶性血管内皮生长因子1、AT1-AA与子痫前期
10.The Role of Soluble Vascular Endothelial Growth Factor Receptor Flt-1(sFlt-1) in Atherosclerotic Plaque可溶性血管内皮生长因子受体Flt-1（sFlt-1）对动脉粥样硬化斑块的作用
11.Cloning and construction of eukaryotic-expression vector carring human soluble vascular endothelial growth factor receptor-1 gene人可溶性血管内皮生长因子受体1基因克隆及真核表达载体的构建
12.Alteration and Roles of Soluable Vascular Endothelial Cell Growth Factor Receptor 1 in Preeclampsia;可溶性血管内皮生长因子受体1在妊娠高血压综合征中的变化及意义
13.Prediction and approach related to the incidence of pre-eclampsia of vascular endothelial growth factor and its soluble receptor-1 level change血管内皮生长因子及可溶性受体-1水平变化对子痫前期发病的预测探讨
14.Detection of vascular endothelial growth factor and its soluble receptor in serum in the prognosis of preeclampsia孕妇血清血管内皮细胞生长因子及其可溶性受体测定对子痫病情的预测及判断
15.The Effect of Dendritic Cell Transfected by Soluble Vascular Endothilial Growth Factor Receptor 2 Gene on Experimental Lung Cancer Metastasis in Mice;可溶性血管内皮生长因子受体基因转染树突状细胞的抗肺癌转移作用
16.Expression of Vascular Endothelial Growth Factor and Soluble Fms-like Tyrosine Kinase Receptor 1 under Different Oxygen Condition in the Primary Cultured Cytotrophoblasts Cells;不同氧浓度对人早孕绒毛细胞滋养层细胞血管内皮生长因子及其可溶性受体表达的影响
17.Expression and significance of IGF-1R and VEGF in gastric carcinoma胰岛素样生长因子-1受体和血管内皮生长因子在胃癌中的表达
18.The Expression of Vascular Endothelial Growth Factor Receptor1 and Progesterone Receptor in Patient with Uterine Leiomyoma;血管内皮生长因子受体1及孕激素受体在子宫肌瘤中的表达
相关短句/例句
soluble fms-like tyrosine kinase-1(sFlt-1)可溶性血管内皮生长因子受体-1(sFlt-1)
3)Soluble fms-like tyrosine kinase receptor 1可溶性血管内皮生长因子受体1
1.OBJECTIVETo investigate the diagnostic value of detecting soluble endoglin and soluble fms-like tyrosine kinase receptor 1 in maternal plasma.目的探讨可溶性CD105淋巴细胞抗原(soluble endoglin,sEng)和可溶性血管内皮生长因子受体1(soluble fms-like tyrosine kinase receptor 1,sFlt-1)在子痫前期患者血清中表达水平的变化及意义;找到一种能够早期预测和筛选子痫前期的简单并且灵敏的方法。
4)Soluble vascular endothelial glowth factor receptor Flt-1可溶性血管内皮生长因子受体Flt-1
5)Soluble VEGF receptor 2可溶性血管内皮生长因子受体-2
6)solubility kinase insert domain receptor可溶性血管内皮生长因子受体
1.Objective To observe the effects of target solubility kinase insert domain receptor(sKDR)on proliferation and apoptosis of human bladder cancer T24 cells and the feasibility and effectiveness of sKDR gene as the target of bladder cancer gene therapy.目的:观察靶向可溶性血管内皮生长因子受体(sKDR)对膀胱癌细胞增殖和凋亡的影响,探讨KDR基因作为膀胱癌基因治疗靶点的可行性和有效性。
延伸阅读
血管内皮生长因子分子式：CAS号：性质：又称血管通透因子(vascular permeability factor)。1989首先从牛垂体滤泡状细胞培养液中分离纯化。有四种不同形式，成熟单体，分别为121，165，189和206个氨基酸，目前分离得到的VEGF，均由两个相同多肽链通过二硫键构成的同源二聚体，亚基分子量18 000～24 000，总蛋白分子量34 000～46 000。蛋白质表面有许多阳离子，呈强碱性，等电点高，对酸碱热稳定。VEGF是一类糖蛋白，可与肝素结合，多糖链仅与其分泌功能有关，与生物活性无关。VEGF 121/165为可溶性分泌蛋白。VEGF 189/206几乎都结合在质膜或基底膜上的含有肝素的蛋白聚糖上。四种VEGF的生物活性无明显差异。VEGF是一类多功能生长因子，能特异性作用于血管内皮细胞，强烈促进其增殖，促进血管形成，并有升高血管通透性的作用。多种细胞有分泌VEGF的功能，并通过旁分泌方式作用于血管内皮细胞。对血管内皮细胞的促有丝分裂作用十分强烈，可明显促进血管生成，能引起血管通透性增加，且是最强烈的引起血管通透性增加的物质。1nmol/L即可起作用，为组胺的50 000倍。用于心血管疾病、肿瘤、创伤修复等。
